TP53 and astrocytoma (excluding glioblastoma): Secondary GB constitutes 5% of cases and develops from astrocytomas with a lower degree of malignancy, affects younger patients and is related to mutations in isocitrate dehydrogenase 1 and 2 (IDH 1 and 2) and tumor protein 53 (P53) [7].